Jazz Pharmaceuticals (Germany) Analysis
| J7Z Stock | EUR 118.05 3.10 2.70% |
Jazz Pharmaceuticals plc is undervalued with Real Value of 125.56 and Hype Value of 118.05. The main objective of Jazz Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Jazz Pharmaceuticals plc is worth, separate from its market price. There are two main types of Jazz Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Jazz Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Jazz Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Jazz Pharmaceuticals stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Jazz Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Jazz |
Jazz Stock Analysis Notes
About 93.0% of the company shares are owned by institutional investors. The book value of Jazz Pharmaceuticals was currently reported as 43.65. The company recorded a loss per share of 0.26. Jazz Pharmaceuticals plc had not issued any dividends in recent years. Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc. Codiak BioSciences, Inc. Pfenex, Inc. and XL-protein GmbH. JAZZ PHARMACEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1460 people. To learn more about Jazz Pharmaceuticals plc call Bruce Cozadd at 353 1 634 7800 or check out https://www.jazzpharma.com.Jazz Pharmaceuticals plc Investment Alerts
| The company has €6.02 Billion in debt which may indicate that it relies heavily on debt financing | |
| The company reported the revenue of 3.09 B. Net Loss for the year was (329.67 M) with profit before overhead, payroll, taxes, and interest of 2.88 B. | |
| Over 93.0% of the company shares are owned by institutional investors |
Jazz Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.38 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jazz Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Jazz Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Jazz Profitablity
Jazz Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Jazz Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Jazz Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Jazz Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Jazz Pharmaceuticals' profitability requires more research than a typical breakdown of Jazz Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.27 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.27. Technical Drivers
As of the 13th of January 2025, Jazz Pharmaceuticals retains the Market Risk Adjusted Performance of 2.43, risk adjusted performance of 0.1177, and Downside Deviation of 1.76. Jazz Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Jazz Pharmaceuticals plc mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and information ratio to decide if Jazz Pharmaceuticals is priced fairly, providing market reflects its last-minute price of 118.05 per share.Jazz Pharmaceuticals plc Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Jazz Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Jazz Pharmaceuticals plc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Jazz Pharmaceuticals Outstanding Bonds
Jazz Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Jazz Pharmaceuticals plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Jazz bonds can be classified according to their maturity, which is the date when Jazz Pharmaceuticals plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| International Game Technology Corp BondUS460599AD57 | View |
Jazz Pharmaceuticals Predictive Daily Indicators
Jazz Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Jazz Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Jazz Pharmaceuticals Forecast Models
Jazz Pharmaceuticals' time-series forecasting models are one of many Jazz Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jazz Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Jazz Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Jazz Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jazz shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Jazz Pharmaceuticals. By using and applying Jazz Stock analysis, traders can create a robust methodology for identifying Jazz entry and exit points for their positions.
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. Jazz Pharmaceuticals plc has licensing and collaboration agreements with ImmunoGen, Inc. Codiak BioSciences, Inc. Pfenex, Inc. and XL-protein GmbH. JAZZ PHARMACEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1460 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Jazz Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Complementary Tools for Jazz Stock analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |